Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Agios Pharmaceuticals (AGIO) over the last 5 years, with Q4 2025 value amounting to $802.5 million.

  • Agios Pharmaceuticals' Treasury Shares changed 0.0% to $802.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $802.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $802.5 million for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Treasury Shares of $16.2 million as of Q4 2025, which was down 0.0% from $16.2 million recorded in Q3 2025.
  • Agios Pharmaceuticals' 5-year Treasury Shares high stood at $16.2 billion for Q1 2022, and its period low was $7.1 million during Q1 2021.
  • Its 5-year average for Treasury Shares is $7.8 billion, with a median of $5.3 billion in 2021.
  • Over the last 5 years, Agios Pharmaceuticals' Treasury Shares had its largest YoY gain of 5168.52% in 2022, and its largest YoY loss of 0.0% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Treasury Shares (Quarter) stood at $802.5 million in 2021, then changed by 0.0% to $802.5 million in 2022, then changed by 0.0% to $802.5 million in 2023, then changed by 0.0% to $802.5 million in 2024, then changed by 0.0% to $802.5 million in 2025.
  • Its last three reported values are $802.5 million in Q4 2025, $802.5 million for Q3 2025, and $802.5 million during Q2 2025.